Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade and melphalan with ASCT in AL amyloidosis
NCT00790647Phase 2Completed
- Sponsor
- Boston Medical Center
- Start
- Jun 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in amyloid light chain amyloidosis, sponsored by Boston Medical Center. Started Jun 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT00790647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790647.